Skip to main content
. 2022 Dec 29;32(2):326–341. doi: 10.1007/s00044-022-02970-3

Fig. 5.

Fig. 5

3-D images of the postdocking interactions of the six NAs, riboprine, forodesine, tecadenoson, nelarabine, vidarabine, and maribavir, and the two reference drugs, remdesivir and molnupiravir, respectively, with the SARS-CoV-2 ExoN “nsp14” enzyme cocrystallized with its protein cofactor nsp10 (PDB ID: 7MC6)